Cite

HARVARD Citation

    Reddy, K. et al. (2017). Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre‐existing renal disease. Hepatology research. 47 (12), pp. 1340-1345. [Online]. 
  
Back to record